FDA issues emergency authorization of Chloroquine for Coronavirus treatment

The US Food and Drug Administration (FDA) has approved the emergency use of anti-malaria drugs Chloroquine – and hydroxychloroquine - for the treatment of patients for COVID-19, with Nigerian counterpart asking local drug manufacturers to commence immediate production of the former. The move by

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```